Skip to contentM
Marimed Inc.
M
MRMDMarimed Inc. Q4 2019 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$34.22M$34.22Mderived+894.8% vs Q4 2018 Net Income-$78.44M-$78.44MderivedN/M vs Q4 2018 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Marimed Inc. · CIK 1522767 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$2,813,164+3.3% Operating Incomederived-$47,630,817N/M Operating Cash Flowderived$44,184N/M Free Cash Flowderived-$2,882,705N/M Margins · derivedGross margin8.2%−70.9 pt vs Q4 2018
Operating margin-139.2%+4.0 pt vs Q4 2018
Net margin-229.2%−4.1 pt vs Q4 2018
ended Dec 31, 2019 · filed Apr 1, 2020 · 92 d after period end